Synthesis and structure-activity relationship studies of tyrosine-based antagonists at the human P2X7 receptor

被引:18
|
作者
Lee, Ga Eun
Joshi, Bhalchandra V.
Chen, Wangzhong
Jeong, Lak Shin
Moon, Hyung Ryong
Jacobson, Kenneth A.
Kim, Yong-Chul
机构
[1] GIST, Dept Life Sci, Kwangju 500712, South Korea
[2] NIH, Natl Inst Diab & Digest & Kidney Dis, Lab Bioorg Chem, Bethesda, MD USA
[3] Ewha Womans Univ, Coll Pharm, Lab Med Chem, Seoul 120750, South Korea
[4] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea
关键词
P2X(7) receptor; tyrosine-based antagonists; ethidium bromide uptake; IL-1 beta release;
D O I
10.1016/j.bmcl.2007.11.077
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Analogues of the P2X(7) receptor antagonist KN-62, modified at the piperazine and arylsulfonyl groups, were synthesized and assayed at the human P2X(7) receptor for inhibition of BzATP-induced effects, that is, uptake of a fluorescent dye (ethidium bromide) in stably transfected HEK293 cells and IL-1 beta release in differentiated THP-1 cells. Substitution of the arylsulfonyl, moiety with a nitro group increased antagonistic potency relative to methyl substitution, such that compound 21 was slightly more potent than KN-62. Substitution with D-tyrosine in 36 and sterically bulky tyrosyl 3,5-dimethyl groups in 9 enhanced antagonistic potency. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:571 / 575
页数:5
相关论文
共 50 条
  • [21] Novel P2X7 receptor antagonists.
    Alcaraz, L
    Bent, J
    Bowers, K
    Donald, D
    Fagura, M
    Furber, M
    Laurent, C
    Lawson, M
    Mortimore, M
    McCormick, M
    Robertson, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2001, 221 : U45 - U45
  • [22] Agonists and antagonists acting at P2X7 receptor
    Baraldi, PG
    Di Virgilio, F
    Romagnoli, R
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2004, 4 (16) : 1707 - 1717
  • [23] Synthesis and structure-activity relationship of uracil nucleotide derivatives as antagonists of human P2Y6 receptor
    Meltzer, Diana
    Ben Yaacov, Ofir
    Arguin, Guillaume
    Nadel, Yael
    Gendron, Fernand-Pierre
    Fischer, Bilha
    PURINERGIC SIGNALLING, 2014, 10 (04) : 783 - 783
  • [24] Roles of P2X7 Receptor in Glial and Neuroblastoma Cells: The Therapeutic Potential of P2X7 Receptor Antagonists
    Synthia H. Sun
    Molecular Neurobiology, 2010, 41 : 351 - 355
  • [25] Roles of P2X7 Receptor in Glial and Neuroblastoma Cells: The Therapeutic Potential of P2X7 Receptor Antagonists
    Sun, Synthia H.
    MOLECULAR NEUROBIOLOGY, 2010, 41 (2-3) : 351 - 355
  • [26] Endothelin receptor antagonists: An overview of their synthesis and structure-activity relationship
    Iqbal, J
    Sanghi, R
    Das, SK
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (04) : 381 - 408
  • [27] DESIGN, SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIP STUDIES FOR IMIDAZOLYL QUINOXALINES AS AMPA RECEPTOR ANTAGONISTS
    OHMORI, J
    SHIMIZUSASAMATA, S
    OKADA, M
    SAKAMOTO, S
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 207 : 178 - MEDI
  • [28] Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists
    Doller, D
    Chackalamannil, S
    Czarniecki, M
    McQuade, R
    Ruperto, V
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (06) : 901 - 906
  • [29] Synthesis and activity of N-cyanoguanidine-piperazine P2X7 antagonists
    Betschmann, Patrick
    Bettencourt, Brian
    Donnelly-Roberts, Diana
    Friedman, Michael
    George, Jonathan
    Hirst, Gavin
    Josephsohn, Nathan
    Konopacki, Donald
    Li, Biqin
    Maull, John
    Morytko, Michael J.
    Moore, Nigel StJohn
    Namovic, Marian
    Rafferty, Paul
    Salmeron-Garcia, Jose-Andres
    Tarcsa, Edit
    Wang, Lu
    Woller, Kevin
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (14) : 3848 - 3851
  • [30] The P2X7 Receptor Channel: Recent Developments and the Use of P2X7 Antagonists in Models of Disease
    Bartlett, Rachael
    Stokes, Leanne
    Sluyter, Ronald
    PHARMACOLOGICAL REVIEWS, 2014, 66 (03) : 638 - 675